Investors
Contact
en
Global United States
Overview iTrack™ iTrack™ Advance Molteno3®
Overview Team AlphaRET
Overview ASX Announcements Presentations Share Registry Board of Directors Corporate Governance Capital Raise

Made with.
Made for.
Ophthalmologists.

Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.

Learn More

Lighting the way
in canaloplasty

Learn more

Latest News

See all

iTrack™ Canaloplasty to be Featured in 31 Presentations in the Official 2024 ASCRS Annual Meeting

Media Release General iTrack Molteno3 AlphaRET

22 Mar, 2024

Retail Entitlement Offer Complete

ASX Announcement General iTrack Molteno3 AlphaRET

15 Mar, 2024

Record USA Sales for February 2024

ASX Announcement General iTrack Molteno3 AlphaRET

5 Mar, 2024

Superwomen
in ophthalmology

Every day thousands of women are making a positive, unique and important impact on the field of ophthalmology.

Tell us your story!

Latest Events

See all

International Congress of Glaucoma Surgery (ICGS)

Abu Dhabi

18 - 20 Apr, 2024

Register for updates

Asia Pacific Glaucoma Congress (APGC) 2024

Manila, Philippines

24 - 26 May, 2024

Register for updates

European Glaucoma Society (EGS) 2024

Dublin, Ireland

1 - 5 June, 2024

Register for updates

Visit us at the AGS 2024

29 Feb - 3 March. More info on the event page.

Contact Us

View our privacy policy
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More